1. Home
  2. AKR vs RCUS Comparison

AKR vs RCUS Comparison

Compare AKR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

N/A

Current Price

$20.98

Market Cap

2.7B

Sector

Real Estate

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$20.03

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AKR
RCUS
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
1993
2018

Fundamental Metrics

Financial Performance
Metric
AKR
RCUS
Price
$20.98
$20.03
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$22.00
$28.89
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
02-10-2026
02-24-2026
Dividend Yield
3.81%
N/A
EPS Growth
18.54
N/A
EPS
0.12
N/A
Revenue
$389,489,000.00
$240,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.18
N/A
P/E Ratio
$170.09
N/A
Revenue Growth
6.01
N/A
52 Week Low
$16.98
$6.50
52 Week High
$24.95
$26.40

Technical Indicators

Market Signals
Indicator
AKR
RCUS
Relative Strength Index (RSI) 62.83 42.95
Support Level $19.68 $19.91
Resistance Level $19.86 $22.29
Average True Range (ATR) 0.41 1.10
MACD 0.10 -0.19
Stochastic Oscillator 100.00 18.35

Price Performance

Historical Comparison
AKR
RCUS

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: